Sage Journals: Discover world-class research

Abstract

Background

Propofol and remifentanil intravenous combination is one popular form of total intravenous anesthesia (TIVA) in mainstream clinical practice, but it has rarely been applied to a rat model for laryngoscopy and laryngeal electromyography (LEMG). Our objective was to establish a safe and reproducible general anesthetic protocol for laryngoscopy and endoscopic LEMG in a rat model. Our hypothesis is that TIVA allows a minimally morbid, and feasible laryngoscopy and LEMG.

Methods

Sprague Dawley rats were subjected to either inhalational anesthesia (IA) (isoflurane) or TIVA (propofol and remifentanil) and underwent laryngoscopy and LEMG. The primary outcome was a complete minimally interrupted rigid laryngoscopy and obtaining reproducible motor unit potentials from the posterior cricoarytenoid muscles. The secondary outcome was morbidity and mortality.

Results

Seventeen out of twenty-two rats underwent both TIVA and IA. Only two underwent IA only. All nineteen rats that underwent IA had a successful experiment. Seventeen rats underwent TIVA, however, only nine completed a successful experiment due to difficulty achieving a surgical plane, and respiratory events. Upon comparing the success of the two anaesthetic regimens, IA was superior to TIVA (P = 0.0008). There was no statistical difference between the amplitudes (p = 0.1985) or motor units burst duration (p = 0.82605) of both methods. Three mortalities were encountered, one of which was due to lidocaine toxicity and two were during anesthetic induction. Respiratory related morbidity was encountered in two rats, all seen with TIVA.

Conclusions

TIVA is not an ideal anesthetic regimen for laryngeal endoscopy and LEMG in rat models. Contrary to our hypothesis, IA did not affect the quality of the LEMG and allowed a seamless rigid endoscopy.

Keywords

Laryngeal mobility disorders Laryngeal electromyography Inhalational anesthesia Total intravenous anesthesia

Background

The standards of general anesthesia for airway endoscopy in humans have evolved due to developing technological and pharmacological innovations. One of the most challenging diagnoses to establish in laryngology is mobility disorders, particularly in children where endoscopy under general anesthesia, supplemented accordingly by laryngeal electromyography (LEMG) is the reference standard.

Traditionally, inhalational anesthesia (IA) was routinely employed for airway endoscopy in clinical practice. In the late 1990's, total intravenous anesthesia (TIVA) technique was introduced and gained popularity [1]. But to this day, proponents of both options argue their cases strongly. The claimed advantages of IA include speed, ease and comfortable induction using a mask in the absence of intravenous (IV) access, in addition to simple non-invasive evaluation of the blood tension of the inhaled agent [2]. On the other hand, TIVA is professed to lessen postoperative nausea and vomiting, act rapidly and independently from the alveolar ventilation, and is administrable using peripheral locations away from airway instrumentation. It is also a non-pollutant for the operative room environment [2–4].

Some experts in airway endoscopy and electromyography studies support the notion that anesthetic agents may modify the findings. It is proposed that different concentration and duration of IA may modify LEMG findings and produce spurious abnormalities. Some rest this notion on evidence from literature pertaining to spine surgery [5–8]. However, many centers perform LEMG in humans under IA [9–12], especially that there are no head to head studies comparing the two techniques. In rats, LEMG has also been performed under IA [13], yet in most cases it has been used as an induction agent for sedation [14–17].

Propofol and remifentanil IV combination is one popular form of TIVA in mainstream clinical practice, but it has rarely been applied to a rat model for laryngoscopy and LEMG. We therefore set out to evaluate whether a TIVA protocol is applicable to the rat model for reproducible assessment of laryngeal function, with minimal morbidity. We specifically aimed to compare the mortality, morbidity, and reproducibility of two general anesthetic protocols for laryngoscopy and endoscopic LEMG in a rat model. Our hypothesis was that TIVA allows a minimally morbid, and feasible laryngoscopy and LEMG.

Methods

Study design

The experiment was conducted in accordance with the Canadian Council of Animal Care guidelines and policies, following approval from the University of Alberta Health Research Ethics Board (AUP00001311) and the Animal Care and Use Committee for health sciences at the University of Alberta.

This prospective comparative non-randomized, cross over experimental animal study was conducted at the Surgical Medical Research Institute and Katz Group - Rexall Centre for research at the University of Alberta, between April 2016 and February 2017.

After induction of general inhalation anesthesia using isofluorane (2% in air; IA) to set up vein cannulation, anesthesia was maintained under one of the two anesthetic options followed by the second one (i.e TIVA followed by IA or vice versa) allowing a washout period to occur in between, during which the animal shows a positive toe pinch reflex.

Study subjects

A total of 30 Sprague-Dawley rats were approved for this study. All rats were housed in pairs within the housing facility of Health Sciences Laboratory Animal Services at the University of Alberta. Eight rats were used initially as a pilot study.

Experimental procedure

Preparation and anesthesia

Pre-operatively, age, sex, and weight of the rats were documented and a unique identifying number was given. Rats were then placed in an induction chamber saturated with 2% isoflurane. Anesthesia was maintained using either inhaled isoflurane 1.5–5% or a combination of propofol (10 mg/ml and 40–50 mg/kg/h IV infusion) [18] and remifentanyl (5 mcg/ml and 0.4 mcg/kg/min IV infusion) [19] after establishing IV access (either via tail or femoral vein). Ampicillin (50 mg/kg SC), meloxicam (1-2 mg/kg SC) and ringer's lactate (1 ml/kg/hr. intraperitoneal) were administered preoperatively. The rat was then transferred to the surgical table and placed on a restraining board with an integrated circulating fluid heating pad with temperature set at 37 °C. A respiratory belt (Kent Scientific Co., USA), a rectal thermometer probe and a vital signs monitoring foot sensor (STARR Life Sciences® Mouse Ox® Plus) were attached. The depth of anesthesia was determined by eliciting a toe pinch reflex, observing the respiratory rate and pattern of breathing, and finally the tolerance and response to airway stimulation to endoscope insertion. If TIVA was used for maintenance, isoflurane concentration was reduced to 0.5%, and then turned off after a period of five minutes. The depth of the anesthesia was then assessed again and the rate of infusion was adjusted accordingly. Baseline and periodic readings of heart and respiratory rate, peripheral capillary oxygen saturation (SpO2), temperature and mucous membrane color were all recorded every five minutes.

Laryngoscopy and laryngeal EMG

Once the rat was adequately anesthetized under either IA or TIVA, room air (21% O2) was delivered through the nasal mask for 1–2 min to maintain SpO₂ above 90%. The rat was then positioned supine on the experimental workstation inside a Faraday cage. By retracting the tongue, the larynx was visualized and lidocaine 1% (1.67 mg/kg) was applied topically under telescopic guidance. A nebulizer was also connected to the nasal cone and lidocaine 1% was delivered for ∼ 1 min. This step was aborted in future experiments after presumed lidocaine toxicity mortality was encountered.

Laryngoscopy

While the animal was spontaneously breathing, a zero degree 2.7 mm rod lens telescope (KARL-STORZ®, Germany) connected to an image capture unit, was used to visualize vocal cords’ movements.

Laryngeal electromyography

Once the larynx was exposed, LEMG recordings from the posterior cricoarytenoid (PCA) muscle were obtained by inserting a monopolar needle electrode (29GA, 37 mm) (Rochester Electro-Medical, USA) transorally under direct rigid endoscopic visualization with each anesthetic regimen. Since the PCA muscle is responsible for vocal cord abduction during inspiration, in addition to the ease of electrode insertion in comparison to other adductor intrinsic laryngeal muscles in the tenuous rat airway, we elected to choose it as our muscle of choice to obtain LEMG recordings. A ground electrode (27G, 12 mm) (Ambu® Neuroline Subdermal, Malaysia) was secured into the chest. Electrodes were connected to amplifiers (AM Systems, Carlsborg, WA) and activity was filtered between 300 Hz and 1 kHz, amplified at x10k and sampled at 1 kHz (Powerlab 16/30; AD Instruments, Colorado Springs, CO). A piezoelectric chest belt was connected to the recording system in order to detect chest wall movements and correlate between LEMG signal and the respiratory cycle. A minimum of ten respiratory cycles was digitally recorded from the muscle for off-line analysis.

Recovery, postoperative care and euthanasia

Upon the conclusion of the experiment the rat was transferred to a new cage to allow recovery from anesthesia. Each rat was housed individually for 2 h post-operatively to be monitored and assessed clinically every fifteen minutes. This included activity, response to external stimuli, appearance and feeding. The animal was then euthanized by decapitation under isoflurane anesthesia.

Outcome measures

Primary outcomes: Proportion of complete rigid laryngoscopy and LEMG

A successful experiment was defined as completion of both laryngeal endoscopy and the ability to obtain a reliable LEMG recording. A complete laryngoscopy was defined as a minimally interrupted, well-tolerated rigid endoscopy of the respiratory action of the larynx while the subject goes through ten cycles of spontaneous breathing. For LEMG, ten consecutive respiratory related bursts of activity were required and the mean amplitudes and burst durations of the LEMG signal were analyzed and calculated using Lab ChartPro8.

Criteria used to abort the experiment included: signs of hemodynamic instability encountered during intraoperative monitoring (persistent maximal scores of respiratory distress, i.e. apnea/hypopnea, or sustained heart rate deviations) or a ninety minutes maximum duration as a cut-off point to achieve the appropriate depth of anesthesia.

Secondary outcomes: Mortality and morbidity

Mortalities encountered were documented. Morbidities experienced were defined as respiratory events during the procedure, which included laryngeal spasm, apnea and hypopnea requiring interruption of the procedure.

Statistical analysis

Demographics were summarized as means, standard deviation (SD), minimal and maximal values. Student t-test was used for comparing means, and 95% confidence intervals were provided. Fisher's exact test and chi square were used to compare proportions of mortality and morbidity between anesthetic regimens [20].

Based on a previous study from our laboratory using only propofol as TIVA [18], a 70% respiratory morbidity rate was demonstrated. A decision was made that a reduction to 15% would be statistically and clinically significant. Based on 16.67% mortality rate and accepting a p value of 0.05 and a power of 80%, the sample size would be ten per group. Allowing for unforeseen morbidity, five rats were added to each group for a total of 30 rats.

As part of the LEMG waveform evaluation, we included motor unit potential assessment in the form of amplitude and burst duration. The amplitude was calculated from the height, the burst duration from the period and 60 divided by the period to obtain the respiratory rate using peak analysis in Lab ChartPro8.

Results

A total of 30 rats were used. The mean age was 7.56 ± 5.79 months (3–18). Thirteen were males and seventeen were females. The mean weight was 509.02 ± 258.24 g (245–1200). The basic clinical parameters for the two groups are described in Table 1. All 8 rats from the pilot group underwent TIVA and two of them underwent a successful experiment.

Table 1

Parameters of the rats

Parameter	TIVA (n = 17)	IA (n = 19)
Age (months) Mean ± SD (range)	7.18 ± 6.1 (3–18)	6.74 ± 5.9 (3–18)
Males	9	9
Females	8	10
Weight (gm) Mean ± SD (range)	514.88 ± 219.28 (245–980)	488 ± 217.95 (245–980)

Seventeen (77.3%) rats underwent both TIVA and IA, two (9.1%) underwent IA only. Three (13.6%) mortalities were encountered in total. Two of them occurred during anesthetic inhalational induction and one mortality was likely due to lidocaine toxicity while on IA. Eight rats (47.06%) were maintained with TIVA first followed by IA and twelve (52.94%) were maintained with IA first followed by TIVA. See Fig. 1.

Fig. 1

General scheme of the study

All nineteen rats that underwent IA had a successful experiment requiring a maximum period of 15 min, i.e. tolerated endoscopy without major respiratory events and completed a reproducible LEMG. Out of the 17 rats that underwent TIVA, nine of them (52.94%) completed a successful experiment requiring a duration between 45 and 90 min. See Fig. 2. The eight unsuccessful experiments (47.06%) were mainly due to inability to achieve an appropriate anesthetic plane. Seven of these rats continued to be responsive and intolerant of endoscopy despite escalation of the TIVA dosage to as high as 3.5 times the weight and boluses, whereas one animal developed bradycardia down to 70 beats per minute and the SpO₂ dropped to 60%, and the procedure was aborted to ensure safety. In the nine successful experiments under TIVA, no mortalities were encountered. However, two rats (11.76%) developed apneic events for seconds during the procedure and recovered spontaneously.

Fig. 2

Successful experiments under TIVA and IA

While the rats were maintained on IA, no morbidities were encountered. Only one (5.26%) mortality took place (presumably due to lidocaine toxicity). Comparing both anesthetic regimens, no statistical significance was evident for morbidity (p = 0.096) or mortality (p = 0.679), however, IA proved to be superior to TIVA in performing successful experiments (p = 0.0008).

With regards to LEMG variables, it was noted that the mean amplitude of LEMG in TIVA is 66.9% that of IA. However, there was no significant difference between mean amplitudes − 1.79 ± 9.88 mV (95% CI -1.79-2.2, p = 0.1985) or mean burst duration 0.27 ± 0.75 s (95% CI -0.23-0.76, p = 0.82605). See in the Additional file 1: Table S1 for details.

Two rats had the electrode maintained in the same position without manipulations while the anesthetic regimens were switched. No statistical difference in mean amplitude or mean burst duration was evident individually (p > 0.05) despite the amplitude being lower on TIVA. The PCA contraction displays a pre-inspiratory pattern of activity in both IA and TIVA consistently. See Fig. 3.

Fig. 3

Respiration and LEMG recordings. Respiration and LEMG recording from PCA muscles under TIVA (Red) and isoflurane IA (Black). a PCA LEMG recording from a rat initially under TIVA anesthesia and transitioning to IA. Recordings include chest belt measurement to determine respiratory activity (top), the raw LEMG measurement from the PCA muscles (middle) and the integrated LEMG signal (bottom). b A 30 s inset of the recording under TIVA. c A 30 s inset of the recording under isoflurane

Of note, the time required to perform a full experiment using IA was 10–15 min compared to 45–90 min when using TIVA.

When comparing clinical parameters during the recovery period, no morbidities or mortalities occurred during recovery.

Discussion

This study compared the use of TIVA and IA during laryngoscopy and LEMG recording in rat models. Our endpoints were the ability to perform a complete endoscopy and neurophysiological recordings with the least morbidity and mortality. Our results show that TIVA is unlikely to be the anesthetic of choice for endoscopy and LEMG recordings in a rat model.

Balancing adequate depth of anesthesia and stability of spontaneous respiration during pediatric endoscopic surgery may be difficult to maintain using TIVA [21, 22]. Additionally, drug dosing appears more demanding with TIVA and higher infusion rates are sometimes necessary to provide the desired plasma concentrations [2]. Malik and Sen [23] reported 5.3% respiratory related morbidity manifested as brief episodes of desaturation due to malposition of the airway and laryngospasm with intermittent TIVA for pediatric endoscopic procedures. On the other hand, evidence suggests that TIVA reduces airway reactivity; decreases bronchospasm and laryngospasm in children [4, 24].

In the current study, the morbidity rate was reduced from 70% based on previous experiments performed by the senior author HE [18] to 11.7% which is considered clinically significant in the current experiment. This may be due to the effect of adding remifentanyl.

Several studies have compared different types of anesthetics regimes in pediatric otolaryngology surgeries. A direct comparison between TIVA (propofol plus remifentanil) and volatile anesthetics indicated that TIVA is superior for induction, maintenance and recovery from anesthesia in children undergoing flexible fiberoptic bronchoscopy, adenoidectomy and/or tonsillectomy [25, 26].

Evidence in pediatric IA suggests that it may cause apnea following induction, especially if great concentrations were delivered [2]. This may explain the unexpected mortalities encountered during induction under IA in our current study.

Several anesthetics in experimental animal models have been used to perform safe, interpretable and reliable endoscopy and/or LEMG, but direct comparisons and proof of reproducibility are limited [13–17, 27–32]. These included intraabdominal barbitone sodium [27], mixture of intramuscular ketamine hydrochloride and xylazine hydrochloride [14, 15, 30] intramuscular ketamine only [28], combination of inhaled isoflurane and intraperitoneal ketamine and xylazine [16, 17, 29, 31], intraperitoneal/intravenous pentobarbital sodium [32], and isoflurane only [13]. With the exception of ketamine and isoflurane, none of these drugs are used in clinical practice. Interestingly, only scant reports on mortality and morbidity have been previously described given the fragility of the animal and its delicate airway, with prior experience indicating up to 20% mortality [13, 18, 33, 34].

Our results indicate that LEMG can be reliably performed under IA in a rat model. Despite previous studies in human spinal surgery [5–8] and animal studies [35] suggesting that the duration and concentration of IA affect evoked electromyogram parameters, specifically amplitude and latency, our results showed no difference in spontaneous LEMG variables between anesthetics. Several LEMG clinical studies [36–39] have used TIVA instead of IA when studying laryngeal disorders. The exact reasons are unclear, perhaps due to the increased use of TIVA among pediatric anesthetists or the potential effect of IA on LEMG.

One important observation in our study is the reduction in the duration of a complete experiment using IA (10–15 min) compared to TIVA (45–90 min). The advantages of using IA compared to TIVA in terms of reduction in induction time, maintenance of stable breathing, lack of laryngeal bronchospasm and emergence from anesthesia has been also reported previously in pediatric studies [21, 40]. In our study, the longer duration required while on TIVA was mainly due to inability to achieve an appropriate anesthetic plane to perform the experiment. This may well be due to IV agents displaying excessive inter-individual variability to TIVA maintenance that cannot be easily estimated [2] or perhaps associated with the large body weight of some rats used for this study and the accumulation of fat mass that may alter the dose necessary to establish the optimal surgical plane.

Tsai and colleagues [41] compared the recovery from laryngoscopy procedures under propofol TIVA and conventional isoflurane in a canine model. The TIVA group was significantly better than the isoflurane group in terms of smoothness of recovery from surgery, defined as absence of struggling, vocalization, or excitement and requiring little or no physical restraint to prevent self-injury. However, the isoflurane group recovered faster from anesthetic. No significant difference was observed between the two groups in terms of adverse effects, which was comparable to our findings.

LEMG is considered a valuable clinical and research tool to assess different pathologies in laryngeal motor function. Its’ use has been described in the literature for humans and in experimental models as an outcome measure following a specific laryngeal intervention. As part of the reporting practice, the type of anesthetic used throughout the procedure should be documented [42]. Proponents of LEMG argue its prognostic and diagnostic values that may guide treatment decisions in patients with vocal fold mobility disorders [37, 43].

Multiple intrinsic laryngeal muscles were described in the literature as a point for recording LEMG activity in both animals and humans. This includes thyroarytenoid [9–12, 15–18, 33, 36–39, 44–49], cricothyroid [44, 46, 48, 50], PCA [11–13, 15, 16, 18, 27, 32, 33, 37, 38, 44, 45, 49, 51, 52] and lateral cricoarytenoid [15] either individually or in combination. The authors have selected the PCA muscle, as it's the single laryngeal muscle responsible for vocal fold abduction. PCA contraction has been pre-inspiratory on a consistent basis noted by the piezoelectric chest belt in our study.

One of the study limitations is the wide range of weight (245 g–980 g) and the large weight potentially contributing in the rat's morbidity and/or mortality while under general anesthesia. Despite the known typical weight of laboratory rats ranging between 300 g and 500 g, mortalities encountered were amongst smaller animals weighing equal to or less than 400 g and morbidities were seen within the mean of weight.

We acknowledge that the monopolar needle electrode was inserted in different locations within the PCA muscle with each anesthetic regimen, which may have affected the LEMG recordings. We are aware that recordings depend on the size of muscle fibers, the proximity of the electrode to large muscles, and the depth of electrode insertion. However, maintaining the electrode in the same position is practically difficult to achieve. A proper washout period between the two anesthetic methods cannot be feasible. Still, we were able to keep the electrode in the same location without manipulation in 2 rats and found no statistical difference in mean amplitude or burst duration.

An additional limitation is the fact that the rats were not blindly randomized for the anesthetic regimens, nor were the results concealed due to the nature of the experiment. However, we used a cross over trial instead. In such case, randomization or which anesthetic was started first does not matter, as the rat will undergo both anesthetic regimens regardless. Also, TIVA and IA are known to have rapid onset/offset action, the effect of anesthetic is reversible, the period of administration is short; the condition is relatively stable as the rats were completely healthy, and the carry-over is not an issue [53]. This permitted convenience and efficiency of the project [54]. This design also allowed amplification of the sample size used.

In the future, we aim to replicate the same experiment in pediatric patients and compare anesthetic regimens and their effect on laryngoscopy and LEMG, as IA is a useful translational model for laryngoscopy and LEMG experiments.

Conclusion

Contrary to our hypothesis, IA did not affect the quality of LEMG and allowed a seamless rigid endoscopy in rat models superior to TIVA. It proved to be quick, easy and safe to administer. We conclude that this is a reliable translational model for laryngoscopy and LEMG experiments.

Footnotes

Funding

This study has been funded by the Edmonton Civic Employees Grant.

Malak Jamal Gazzaz acknowledges her residency scholarship through Umm Al-Qura University, Makkah, Saudi Arabia. SP laboratory is funded by NSERC, CIHR, Canadian Lung Association and Women and Children Health Research Institute.

Availability of data and materials

The datasets during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors’ contributions

MJG contributed to the experimental procedures, data analysis and interpretation, and manuscript preparation. She has approved the final manuscript in its current form. JS contributed to the experimental procedures, data analysis and interpretation. She has approved the final manuscript in its current form. SP contributed to the experimental procedures, oversaw the technical aspects of the research and contributed to manuscript preparation. She has approved the final manuscript in its current form. BT contributed to the experiment conception and design and contributed to the pilot study. He has approved the final manuscript in its current form. CJ contributed to the conception and design of the study, and provided input to the manuscript. She has approved the final manuscript in its current form. HE was responsible for the conception, design, and overall execution of the study. He contributed to the manuscript preparation and has approved the final manuscript in its current form.

Ethics approval and consent to participate

Ethics approval was obtained from the University of Alberta Health Research Ethics Board, Canadian Council on Animal Care guidelines and policy Animal Care and Use Committee for health sciences and University of Alberta's Animal Welfare (Assurance Number: #A5070–01) prior to study commencement.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abbreviations

This work was presented on the podium at the Poliquin Residents Research Competition (Canadian Society of Otolaryngology-Head and Neck Surgery Annual Meeting, June 2018, Quebec City, QC).

References

Malherbe

Whyte

Singh

Amari

King

Mark Ansermino

Total intravenous anesthesia and spontaneous respiration for airway endoscopy in children - a prospective evaluation

Paediatr Anaesth 2010 20 434 438 10.1111/j.1460-9592.2010.03290.x

Lerman

JÖhr

Inhalational anesthesia vs total intravenous anesthesia (TIVA) for pediatric anesthesia

Paediatr Anaesth 2009 19 521 534 10.1111/j.1460-9592.2009.02962.x

McCormack

Total intravenous anaesthesia in children

Curr Anaesth Crit Care 2008 19 309 314 10.1016/j.cacc.2008.09.005

Gaynor

Ansermino

Paediatric total intravenous anaesthesia

BJA Educ 2016 16 369 373 10.1093/bjaed/mkw019

Chen

Wang

Sevoflurane affects evoked electromyography monitoring in cerebral palsy

Open Med 2016 11 138 142 1:CAS:528:DC%2BC1cXmsFyns7s%3D 10.1515/med-2016-0027

Banoub

Tetzlaff

Schubert

Pharmacologic and Physiologic Influences Affecting Sensory Evoked Potentials: implications for perioperative monitoring

Anesthesiology. 2003 3 716 37 10.1097/00000542-200309000-00029

Chong

Manninen

Sivanaser

Subramanyam

Venkatraghavan

Direct comparison of the effect of desflurane and sevoflurane on intraoperative motor-evoked potentials monitoring

J Neurosurg Anesthesiol 2014 26 306 312 10.1097/ANA.0000000000000041

Chen

The effects of isoflurane and propofol on intraoperative neurophysiological monitoring during spinal surgery

J Clin Monit Comput 2004 18 303 308 10.1007/s10877-005-5097-5

Gartlan

Peterson

Hoffman

Luschei

Smith

RJH

Bipolar hooked-wire electromyographic technique in the evaluation of pediatric vocal cord paralysis

Ann Otol Rhinol Laryngol. 1993 102 695 700 1:STN:280:DyaK3szosVWqsA%3D%3D 10.1177/000348949310200909

10.

Wohl

Leshner

Kilpatrick

Shaia

Intraoperative pediatric laryngeal electromyography: experience and caveats with monopolar electrodes

Ann Otol Rhinol Laryngol. 2001 110 524 531 1:STN:280:DC%2BD3MzksVOktA%3D%3D 10.1177/000348940111000606

11.

Berkowitz

Laryngeal electromyography findings in idiopathic congenital bilateral vocal cord paralysis

Ann Otol Rhinol Laryngol. 1996 105 207 212 1:STN:280:DyaK283gt1yltw%3D%3D 10.1177/000348949610500306

12.

Berkowitz

Ryan

Pilowsky

Respiration-related laryngeal electromyography in children with bilateral vocal fold paralysis

Ann Otol Rhinol Laryngol. 2009 118 791 795 10.1177/000348940911801108

13.

McRae

Kincaid

Illing

Hiatt

Hawkins

Halum

Local neurotoxins for prevention of laryngeal Synkinesis after recurrent laryngeal nerve injury

Ann Otol Rhinol Laryngol. 2009 118 887 893 10.1177/000348940911801210 20112524

14.

Tessema

Roark

Pitman

Weissbrod

Sharma

Schaefer

Observations of recurrent laryngeal nerve injury and recovery using a rat model

Laryngoscope 2009 119 1644 1651 10.1002/lary.20293

15.

Pitman

Weissbrod

Roark

Sharma

Schaefer

Electromyographic and histologic evolution of the recurrent laryngeal nerve from transection and anastomosis to mature reinnervation

Laryngoscope 2011 121 325 331 10.1002/lary.21290

16.

Tessema

Pitman

Roark

Berzofsky

Sharma

Schaefer

Evaluation of functional recovery of recurrent larymgeal nerve using transoral laryngeal bibopar electromyography: a rat model

New York 2008 117 604 608

17.

Kupfer

Old

Feldman

Hogikyan

Spontaneous laryngeal reinnervation following chronic recurrent laryngeal nerve injury

Laryngoscope 2013 123 2216 2227 10.1002/lary.24049 23817931

18.

Jomah MA, Jomah MA. Does botulinum toxin type a alter the consequences of recurrent laryngeal nerve transection in the rat model ? By master of science in experimental Surgery University of Alberta. 2014.

19.

Ismaiel

Chankalal

Zhou

Henzler

Using remifentanil in mechanically ventilated rats to provide continuous analgosedation

J Am Assoc Lab Anim Sci. 2012 51 58 62 1:CAS:528:DC%2BC38XisVaqsrw%3D 22330869 3276967

20.

SISA. Simple Interactive Statistical Analysis. http://www.quantitativeskills.com/sisa/index.htm. Accessed 10 Feb 2018.

21.

Yao

Chen

A non-tracheal intubation (tubeless) anesthetic technique with spontaneous respiration for upper airway surgery

Clin Investig Med 2013 36 151 157 10.25011/cim.v36i3.19726

22.

Dilos

Anesthesia for pediatric airway endoscopy and upper gastrointestinal endoscopy

Int Anesthesiol Clin 2009 47 55 62 10.1097/AIA.0b013e3181aeabf5

23.

Malik

Sen

Propofol anesthesia is an effective and safe strategy for pediatric endoscopy [4]

Paediatr Anaesth 2006 16 220 221 10.1111/j.1460-9592.2005.01772.x

24.

Lauder

Total intravenous anesthesia will supercede inhalational anesthesia in pediatric anesthetic practice

Paediatr Anaesth 2015 25 52 64 10.1111/pan.12553

25.

Chen

Fan

Manyande

A comparison between total intravenous anaesthesia using propofol plus remifentanil and volatile induction/maintenance of anaesthesia using sevoflurane in children undergoing flexible fibreoptic bronchoscopy

Anaesth Intensive Care 2013 41 742 749 1:STN:280:DC%2BC2c7it1SitA%3D%3D 24180715

26.

Grundmann

Uth

Eichner

Wilhelm

Larsen

Total intravenous anaesthesia with propofol and remifentanil in paediatric patients: a comparison with a desflurane-nitrous oxide inhalation anaesthesia

Acta Anaesthesiol Scand 1998 42 845 850 1:CAS:528:DyaK1cXlt1entL8%3D 10.1111/j.1399-6576.1998.tb05332.x 9698963

27.

Liu

Dong

Chi

Functional remobilization evaluation of the paralyzed vocal cord by end-to-side neurorrhaphy in rats

Laryngoscope 2005 115 1418 1420 10.1097/01.mlg.0000167982.07597.df

28.

Motoyoshi

Hyodo

Yamagata

Gyo

Restoring vocal fold movement after transection and immediate suturing of the recurrent laryngeal nerve with local application of basic fibroblast growth factor: an experimental study in the rat

Laryngoscope 2004 114 1247 1252 1:CAS:528:DC%2BD2cXltlOrtbk%3D 10.1097/00005537-200407000-00020

29.

Rubin

Hogikyan

Feldman

Potential for promoting recurrent laryngeal nerve regeneration by remote delivery of viral gene therapy

Laryngoscope 2012 122 349 355 1:CAS:528:DC%2BC38XitVKis7Y%3D 10.1002/lary.22436

30.

Shiotani

Nakagawa

Flint

Modulation of myosin heavy chains in rat laryngeal muscle

Laryngoscope 2001 111 472 477 1:CAS:528:DC%2BD3MXitF2isLw%3D 10.1097/00005537-200103000-00017 11224778

31.

Old

Feldman

Hogikyan

Novel model to assess laryngeal function, innervation, and reinnervation

Ann Otol Rhinol Laryngol. 2011 120 331 338 10.1177/000348941112000509

32.

Berkowitz

Chalmers

Sun

QIJ

Pilowsky

Respiratory activity of the rat posterior cricoarytenoid muscle

Ann Otol Rhinol Laryngol. 1997 106 897 901 1:STN:280:DyaK1c%2FjvV2itw%3D%3D 10.1177/000348949710601103

33.

Han

Fan

Characteristics of experimental recurrent laryngeal nerve surgical injury in dogs

Ann Otol Rhinol Laryngol 2009 118 575 580 10.1177/000348940911800808

34.

Sakowski

Heavener

Lunn

Fung

Spratt

Neuroprotection using gene therapy to induce vascular endothelial growth factor-a expression

Gene Ther 2009 16 1292 1299 1:CAS:528:DC%2BD1MXhtVOmu7bP 10.1038/gt.2009.111

35.

Haghighi

Madsen

Green

Oro

Kracke

Suppression of motor evoked potentials by inhalation anesthetics

J Neurosurg Anesthesiol 1990 2 73 78 1:STN:280:DC%2BD2M3mslWltw%3D%3D 10.1097/00008506-199006000-00003

36.

Scott

Chong

Randolph

Hartnick

Intraoperative laryngeal electromyography in children with vocal fold immobility: a simplified technique

Int J Pediatr Otorhinolaryngol 2008 72 31 40 10.1016/j.ijporl.2007.09.011

37.

AlQudehy

Norton

El-Hakim

Electromyography in children's laryngeal mobility disorders: a proposed grading system

Arch Otolaryngol - Head Neck Surg 2012 138 936 941 10.1001/2013.jamaoto.247

38.

Jacobs

Finkel

Laryngeal electromyography in the management of vocal cord mobility problems in children

Laryngoscope 2002 112 1243 1248 10.1097/00005537-200207000-00019

39.

Braun

Chong

Intraoperative laryngeal electromyography in children with vocal fold immobility: results of a multicenter longitudinal study

Arch Otolaryngol Neck Surg 2011 137 1251 1257 10.1001/archoto.2011.184

40.

Liao

Liu

Comparison of sevoflurane volatile induction/maintenance anaesthesia and propofol-remifentanil total intravenous anaesthesia for rigid bronchoscopy under spontaneous breathing for tracheal/bronchial foreign body removal in children

Eur J Anaesthesiol 2010 27 930 934 1:CAS:528:DC%2BC3cXhsVKisLnK 10.1097/EJA.0b013e32833d69ad

41.

Tsai

Y-C

Wang

L-Y

Yeh

L-S

Clinical comparison of recovery from total intravenous anesthesia with propofol and inhalation anesthesia with isoflurane in dogs

J Vet Med Sci 2007 69 1179 1182 1:CAS:528:DC%2BD2sXhsVyhtLvI 10.1292/jvms.69.1179

42.

Blitzer

Crumley

Dailey

Ford

Floeter

Hillel

Recommendations of the Neurolaryngology study group on laryngeal electromyography

Otolaryngol - Head Neck Surg 2009 140 782 793.e6 10.1016/j.otohns.2009.01.026 19467391

43.

Munin

Heman-Ackah

Rosen

Sulica

Maronian

Mandel

Consensus statement: using laryngeal electromyography for the diagnosis and treatment of vocal cord paralysis

Muscle Nerve 2016 53 850 855 10.1002/mus.25090

44.

García-López

Santiago-Pérez

Peñarrocha-Teres

del Palacio

Gavilan

Laryngeal Electromyography in Diagnosis and Treatment of Voice Disorders

Acta Otorrinolaringol 2012 63 458 464 10.1016/j.otoeng.2012.11.008

45.

Yang

An experimental study on the laryngeal electromyography and visual observations in varying types of surgical injuries to the unilateral recurrent laryngeal nerve in the neck

Laryngoscope 1991 101 7 Pt 1 699 708 1:STN:280:DyaK3M3oslCnsA%3D%3D 2062149

46.

Park

Jung

Yoo

Park

Lee

Kim

Clinical usefulness of ultrasonography-guided laryngeal electromyography

J Voice 2016 30 100 103 10.1016/j.jvoice.2015.03.009 26602419

47.

Paniello

West

Lee

Laryngeal Reinnervation with the hypoglossal nerve

Ann Otol Rhinol Laryngol. 2001 110 532 542 1:STN:280:DC%2BD3MzksVOktQ%3D%3D 10.1177/000348940111000607

48.

Kianicka

Diaz

Renolleau

Canet

Praud

Laryngeal and abdominal muscle electrical activity during periodic breathing in nonsedated lambs

J Appl Physiol. 1998 84 669 75 1:STN:280:DyaK1c7js1emtA%3D%3D 10.1152/jappl.1998.84.2.669

49.

Watts

Wozniak

Davenport

Hutchison

Laryngeal and diaphragmatic activities with a single expiratory load in newborn lambs

Respir Physiol 1997 107 27 35 1:STN:280:DyaK2s3ksFWgsA%3D%3D 10.1016/S0034-5687(96)02500-5

50.

Rex

Laryngeal activity during the induction of anaesthesia in the cat

Aust Vet J 1973 49 365 368 1:STN:280:DyaE2c%2Fit1WrsQ%3D%3D 10.1111/j.1751-0813.1973.tb09342.x

51.

Carlo

Kosch

Bruce

Strohl

Martin

Control of laryngeal muscle activity in preterm infants

Pediatr Res 1987 22 87 91 1:STN:280:DyaL2szhs1OitA%3D%3D 10.1203/00006450-198707000-00020

52.

Bliss

Wark

McDonnall

Smith

Functional electrical stimulation of the feline larynx with a flexible ribbon electrode array

Ann Otol Rhinol Laryngol. 2016 125 130 136 10.1177/0003489415601128

53.

Senn

Ezzet

Clinical cross-over trials in phase I

Stat Methods Med Res 1999 8 263 278 1:STN:280:DC%2BD3c7gtVaqsQ%3D%3D 10.1177/096228029900800306

54.

Lui

K-J

Notes on crossover design

Enliven Biostat Metr. 2015 1 1 2

Comparison of inhaled versus intravenous anesthesia for laryngoscopy and laryngeal electromyography in a rat model

Abstract

Background

Methods

Results

Conclusions

Keywords

Background

Methods

Study design

Study subjects

Experimental procedure

Preparation and anesthesia

Laryngoscopy and laryngeal EMG

Laryngoscopy

Laryngeal electromyography

Recovery, postoperative care and euthanasia

Outcome measures

Primary outcomes: Proportion of complete rigid laryngoscopy and LEMG

Secondary outcomes: Mortality and morbidity

Statistical analysis

Results

Discussion

Conclusion

Footnotes

Funding

Availability of data and materials

Authors’ contributions

Ethics approval and consent to participate

Consent for publication

Competing interests

Publisher's Note

Abbreviations

References